03.07.12
Sabinsa Corporation, East Windsor, NJ, has received U.S. patent #8119696, titled “Treatment of superficial and cutaneous mycoses with a pure form of 1,7-bis(4-hydroxy-3-methoxyphenyl)-3,5-heptanedione.” The patent covers the company’s TetraPure ingredient for hair, skin and nails. Protected inventive features include a method of treating superficial and cutaneous mycoses in humans. The superficial and cutaneous mycoses conditions are Pityriasis versicolor, Seborrhoeic dermatitis, dandruff, Follicular pityriasis, Tinea nigra, White piedra, Black piedra and onychomycosis. According to the company, TetraPure is highly effective against a wide range of fungi and therefore a natural replacement for anti fungal agents and topical steroids, which may have significant side effects.
